Acclinate
United States
- Birmingham, AL
- 08/05/2024
- Series A
- $17,000,000
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
- Industry Biotechnology
- Website https://www.acclinate.com/
- LinkedIn https://www.linkedin.com/company/acclinateinc/
Related People
Del Smith, PhDFounder
United States -
Birmingham, Alabama
Dr. Del Smith uses his diverse background in healthcare, IT, higher education, and business to drive greater healthcare equity. He is the CEO and Cofounder of Acclinate, a company using sustained community engagement and AI to mobilize historically marginalized communities for greater equity in healthcare.
Prior to cofounding Acclinate, Del dedicated nearly fifteen years to higher education as a business professor and then Dean of a business school. His research on success factors of minority-owned businesses has been published in journals such as the Journal of Business Research and the Journal of Developmental Entrepreneurship.
Del is a U.S. Army veteran and holds a Ph.D. in Business from the University of Alabama.
Kin Health | $9,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Furientis | $5,000,000 | (May 19, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)